SecurityASPN / Aspen Aerogels Inc. (04523Y105)
President and CEOYoung Donald R
IndustryLumber And Other Construction Materials
Institutional Owners57
Institutional Shares18,845,334 - 78.91%
Common Stock Shares Outstanding23,882,253 shares (as of 2018-03-31)
Institutional Value$ 76,541,000 USD

Institutional Stock Ownership and Shareholders()

ASPN / Aspen Aerogels Inc. Institutional Ownership

Aspen Aerogels Inc. (NYSE:ASPN) has 57 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 18,845,334 shares. Largest shareholders include George Kaiser Family Foundation, Oaktop Capital Management II, L.P., Ariel Investments, Llc, Telemark Asset Management, LLC, Cowen Prime Services LLC, Wellington Trust Co NA, Heartland Advisors Inc, Royce & Associates LLC, Tocqueville Asset Management L.p., and Vanguard Group Inc.
Aspen Aerogels Inc. (NYSE:ASPN) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/aspn"><img src="https://images.fintel.io/us-aspn-so.png" alt="ASPN / Aspen Aerogels Inc. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-11 13F-HR MACQUARIE GROUP LTD 6,401 0 -100.00 31 0 -100.00
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 2,000 2,000 0.00 10 9 -10.00
2018-05-14 13F-HR Telemark Asset Management, LLC 706,500 1,041,500 47.42 3,448 4,447 28.97
2018-02-14 13F-HR Lehman Brothers Holdings Inc. 10,534 0 -100.00 79 0 -100.00
2018-05-10 13F-HR JP Morgan Chase & Co 28,309 31,317 10.63 138 134 -2.90
2018-05-15 13F-HR Harvey Partners, LLC 550,000 2,349
2018-05-15 13F-HR UBS Group AG 1,350 3,100 129.63 7 13 85.71
2018-05-15 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 226,530 181,400 -19.92 1,105 775 -29.86
2017-02-10 13F-HR BlackRock Advisors LLC 81,300 76,976 -5.32 485 318 -34.43
2018-05-15 13F-HR NEEDHAM INVESTMENT MANAGEMENT LLC 600,000 577,850 -3.69 2,928 2,468 -15.71
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 647,130 636,206 -1.69 3,857 2,628 -31.86
2018-05-15 13F-HR RBF Capital, LLC 41,111 41,111 0.00 201 172 -14.43
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 5,795 9,669 66.85 28 42 50.00
2018-05-15 13F-HR PERRITT CAPITAL MANAGEMENT INC 200,000 200,000 0.00 976 994 1.84
2018-04-30 13F-HR REILLY FINANCIAL ADVISORS, LLC 400 400 0.00 2 2 0.00
2018-05-11 13F-HR DIMENSIONAL FUND ADVISORS LP 129,922 160,515 23.55 634 685 8.04
2018-05-14 13F-HR TOCQUEVILLE ASSET MANAGEMENT L.P. 856,055 806,300 -5.81 4,178 3,443 -17.59
2018-05-14 13F-HR AMERIPRISE FINANCIAL INC 849,994 631,144 -25.75 4,147 2,694 -35.04
2018-05-15 13F-HR VANGUARD GROUP INC 582,542 777,526 33.47 2,843 3,320 16.78
2018-04-17 13F-HR Mesirow Financial Investment Management, Inc. 77,429 76,327 -1.42 378 326 -13.76
2017-02-10 13F-HR BlackRock Group LTD 46,838 46,838 0.00 279 193 -30.82
2017-02-09 SC 13G/A Wellington Trust Co NA 1,216,768 916,900 -24.64
2017-02-10 13F-HR BlackRock Japan Co. Ltd 1,461 0 -100.00 9 0 -100.00
2018-05-15 13F-HR BARCLAYS PLC 0 1 0 0
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 5,442 5,442 0.00 27 23 -14.81
2018-05-15 13F-HR JACOBS LEVY EQUITY MANAGEMENT, INC 36,700 22,100 -39.78 179 94 -47.49
2018-05-09 13F-HR BlackRock Inc. 422,949 384,807 -9.02 2,064 1,643 -20.40
2018-05-04 13F-HR PRUDENTIAL FINANCIAL INC 23,400 100
2018-05-09 13F-HR NORTHERN TRUST CORP 37,057 39,660 7.02 181 170 -6.08
2018-04-23 13F-HR Taylor, Cottrill, Erickson & Associates, Inc. 29,000 124
2018-05-14 13F-HR ARIEL INVESTMENTS, LLC 1,090,898 1,202,956 10.27 5,324 5,137 -3.51
2018-04-11 13F-HR Portfolio Solutions, LLC 2,020 2,020 0.00 10 9 -10.00
2018-05-10 13F-HR HEARTLAND ADVISORS INC 927,066 907,424 -2.12 4,524 3,875 -14.35
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 304,145 304,145 0.00 1,484 1,299 -12.47
2018-05-08 13F-HR Neuberger Berman Group LLC 20,000 20,000 0.00 98 85 -13.27
2018-01-30 13F-HR Reservoir Operations, L.P. 2,908,270 0 -100.00 12,651 0 -100.00
2018-04-12 13F-HR ACADIAN ASSET MANAGEMENT LLC 717 1,394 94.42 3 6 100.00
2017-01-18 13F-HR WALL STREET ASSOCIATES 586,200 274,770 -53.13 3,494 1,135 -67.52
2018-04-26 13F-HR ESSEX INVESTMENT MANAGEMENT CO LLC 312,037 290,771 -6.82 1,523 1,242 -18.45
2017-02-10 13F-HR BlackRock Investment Management, LLC 2,925 2,925 0.00 17 12 -29.41
2018-05-15 13F-HR Bank of New York Mellon Corp 27,406 26,754 -2.38 134 114 -14.93
2018-05-04 13F-HR Granite Investment Partners, LLC 199,600 71,689 -64.08 974 306 -68.58
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 305,000 305,000 0.00 1,488 1,302 -12.50
2018-05-15 13F-HR STATE STREET CORP 0 17,324 0 73
2018-05-09 13F-HR GEORGE KAISER FAMILY FOUNDATION 3,167,322 3,167,322 0.00 15,457 13,524 -12.51
2018-05-03 13F-HR Cowen Prime Services LLC 922,924 1,021,461 10.68 4,504 4,362 -3.15
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 94,870 94,870 0.00 462 405 -12.34
2018-05-14 13F-HR MORGAN STANLEY 109,180 96,237 -11.85 533 411 -22.89
2018-05-09 13F-HR GAGNON SECURITIES LLC 39,718 170
2018-05-14 13F-HR Renaissance Technologies LLC 355,000 429,700 21.04 1,732 1,835 5.95
2018-05-11 13F-HR Oaktop Capital Management II, L.P. 1,399,001 1,499,001 7.15 6,827 6,401 -6.24
2017-02-10 13F-HR BlackRock Fund Advisors 43,020 44,500 3.44 256 184 -28.12
2018-05-15 13F-HR DEUTSCHE BANK AG\ 27,078 62,095 129.32 132 264 100.00
2018-05-15 13F-HR Brandywine Global Investment Management, LLC 16,767 13,680 -18.41 82 59 -28.05
2018-05-14 13F-HR Royce & Associates LLC 701,408 839,642 19.71 3,423 3,585 4.73
2018-05-10 13F-HR AWM Investment Company, Inc. 1,000,000 320,264 -67.97 4,880 1,368 -71.97
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 30,945 0 -100.00 151 0 -100.00
2018-05-11 13F-HR Russell Investments Group, Ltd. 5,200 5,200 0.00 26 22 -15.38
2018-05-10 13F-HR FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. 15,439 15,439 0.00 75 66 -12.00
2018-05-14 13F-HR Firsthand Capital Management, Inc. 35,000 35,000 0.00 171 149 -12.87
2018-05-07 13F-HR QUANTUM CAPITAL MANAGEMENT 251,264 330,544 31.55 1,226 1,411 15.09
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 132,000 132,000 0.00 644 564 -12.42

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

9h - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

9h - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Related News Stories

Aspen Aerogel's (ASPN) CEO Don Young on Q1 2018 Results - Earnings Call Transcript

2018-05-06 seekingalpha
Aspen Aerogels, Inc. (NYSE:ASPN) Q1 2018 Results Earnings Conference Call May 3, 2018 5:00 PM ET (4-0)

Askeladden Capital - Q1 2018 Letter: 'The Asterisks'

2018-04-02 seekingalpha
In my last letter, I noted that the early days of 2018 had been kind to our portfolio, more or less making up for a frustrating 2017 in which the market rallied without abandon, yet refused to recognize (or actively punished) good fundamentals at most of our portfolio companies. Here's how we're doing now. As always, please remember that we do not use leverage and typically maintain a double-digit cash balance. (195-0)

CUSIP: 04523Y105